Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	4.42B -10.1%
Revenue (ttm)	605.58M -7.4%
Net Income	222.26M -25.1%
EPS	2.76 -24.9%
Shares Out	81.10M
PE Ratio	19.73
Forward PE	n/a
Dividend	1.04 (1.91%)
Ex-Dividend Date	Jul 9, 2025

Volume	228,140
Open	53.52
Previous Close	54.40
Day's Range	53.52 - 54.37
52-Week Range	52.40 - 88.96
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 807
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 593.74 million, a decrease of -6.74% compared to the previous year's 636.63 million. Earnings were 221.71 million, a decrease of -24.43%.